Bio-Rad Laboratories (BIO) Asset Utilization Ratio (2010 - 2026)
Bio-Rad Laboratories' (BIO) quarterly Asset Utilization Ratio came in at 0.25 in Q1 2026, down 50.73% year-on-year from 0.52 in Q1 2025, and little changed on a QoQ basis from 0.25 in Q4 2025.
Bio-Rad Laboratories (BIO) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 17 years of Asset Utilization Ratio data on file, last reported at 0.25 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 50.73% year-over-year to 0.25 in Q1 2026; TTM through Mar 2026 was 0.25, a 50.73% decrease from a year earlier, with the FY2025 full-year figure at 0.26, down 50.25% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.25, roughly flat from 0.25 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for BIO reached as high as 10.36 in Q2 2025 and fell as low as 0.21 in Q2 2022.
- Historically, Asset Utilization Ratio has averaged 1.35 across 5 years, with a median of 0.41 in 2023.
- Across the five-year window, Asset Utilization Ratio soared 1201.1% in 2024 and slumped 90.24% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.46 in 2022, then fell by 7.22% to 0.43 in 2023, then rose by 23.12% to 0.53 in 2024, then slumped by 52.0% to 0.25 in 2025, then dropped by 0.2% to 0.25 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.25 in Q1 2026, 0.25 in Q4 2025, and 0.53 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.25 |
| Sep 30, 2025 | 0.53 |
| Jun 30, 2025 | 10.36 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | 0.53 |
| Mar 31, 2024 | 5.29 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.40 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.20 |
| Mar 31, 2021 | 0.38 |
| Dec 31, 2020 | 0.42 |